← Leaderboards
Eleni Stylianou
Cleveland Clinic Lerner Com-Cwru
$506,237
Attributed
$1,012,474
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $341.5K · FY2012–14$500K$375K$250K$125K$0
'12
'13
'14
Funding mix
By agency
NIH$1,012,474 · 1
By mechanism
R01$1,012,474 · 1
Top collaborators
- Claudio Fiocchi3 shared
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Serpil C. Erzurum$45,061,611
- Carol A. De La Motte$5,818,899
- Robert Fairchild$30,096,034
- Anna Valujskikh$13,893,856
- Bruce D Trapp$26,095,443
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAmplifiersApplications GrantsAutoimmune DiseasesBaseBinding (Molecular Function)Calcium BindingCell DeathCell InjuryCellsChemotactic FactorsChronicColitisCytokineEndothelial CellsEpithelialEpithelial CellsEpitheliumEventExtracellularExtracellular MatrixExtracellular Matrix DegradationFamilyAcute
Grant awards (3)
Epithelial Cell-Derived IL-1-alpha as a Novel Danger Signal in IBD Pathogenesis$341,475
R01 · FY2014 · DK
Epithelial Cell-Derived IL-1-alpha as a Novel Danger Signal in IBD Pathogenesis$329,524
R01 · FY2013 · DK
Epithelial Cell-Derived IL-1-alpha as a Novel Danger Signal in IBD Pathogenesis$341,475
R01 · FY2012 · DK